Journals / Türk Kolon ve Rektum Hastalıkları Dergisi / 2020 / Cilt: 30 - Sayı: 2

The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?

COVID-19 Pandemisi ve Kolorektal Kanser : 5N1K- Neyi, Neden, Nasıl, Nerede, Ne Zaman ve Kime Yapalım?

Pages
67–75
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study discusses how to plan the multimodal treatment of colorectal cancer during the pandemic by using surgical, chemotherapeutic, and radiotherapeutic options while evaluating tailored treatments and the current international guidelines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The treatment of colorectal cancer, which is an important cause of cancer related death and is still an important public health problem, has become a matter of debate due to the COVID-19 pandemic that emerged in December 2019.
📊
Key Findings & Data:This pandemic has forced us to rearrange our entire surgical practice.
💡
Conclusion & Impact:This study discusses how to plan the multimodal treatment of colorectal cancer during the pandemic by using surgical, chemotherapeutic, and radiotherapeutic options while evaluating tailored treatments and the current international guidelines.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

The treatment of colorectal cancer, which is an important cause of cancer related death and is still an important public health problem, has become a matter of debate due to the COVID-19 pandemic that emerged in December 2019. This pandemic has forced us to rearrange our entire surgical practice. However, during these arrangements it should be ensured that patients are less affected by the pandemic, hospital resources should be used more efficiently and the risk of healthcare professionals should be minimized. This study discusses how to plan the multimodal treatment of colorectal cancer during the pandemic by using surgical, chemotherapeutic, and radiotherapeutic options while evaluating tailored treatments and the current international guidelines.

Özet

Kansere bağlı ölümlerin önemli bir nedeni olan ve halen önemli bir toplum sağlığı sorunu olan kolorektal kanserin tedavisi, Aralık 2019’da ortaya çıkan COVID-19 pandemisi nedeniyle tartışma konusu halini almıştır. Yapılacak düzenlemeler hastaların pandemiden daha az etkilenmesini, hastane kaynaklarının pandemi için daha etkili kullanılmasını sağlamalı, sağlık çalışanlarını riske sokmadan planlanmalıdır. Ancak onkolojik ve cerrahi sonuçların bu yapılacak tedavi değişikliklerinden etkilenmemesi ana amaç olmalıdır. Bu çalışmada, kişiselleştirilmiş tedavi ile güncel uluslararası kılavuzlar da tartışılarak, pandemi döneminde kolorektal kanserin cerrahi, kemoterapi, radyoterapi seçenekleri kullanılarak multimodal tedavisinin nasıl planlanacağı tartışılmıştır.

🔖

Cite This Article

UTKAN, G., YILDIZ, F., KUZU, M. A., AKYOL, C., KOÇ, M. A. (2022). The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. Türk Kolon ve Rektum Hastalıkları Dergisi, Cilt: 30 - Sayı: 2, 67–75. https://ajindex.com/articles/634539

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30.
  2. Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2012;131:1649- 1658. ACS. ACS Risk Calculator - Home Page [Internet]. 2019 [cited 2020 Apr 6]. Available from: https://riskcalculator.facs.org/RiskCalculator/ Urgent Intercollegiate General Surgery Guidance on COVID-19 | ACPGBI [Internet]. [cited 2020 Mar 29]. Available from: https://www.acpgbi.org. uk/news/urgent-intercollegiate-general-surgery-guidance-on-covid-19/ COVID-19 Guidelines for Triage of Colorectal Cancer Patients. [cited 2020 Mar 29]; Available from: https://www.facs.org/covid-19/clinical-guidance/ elective-case/colorectal-cancer Considerations for Multidisciplinary Management of Patients with Colorectal Cancer during the COVID- 19 Pandemic. [cited 2020 Mar 29];(5962281):1–10. Available from: https://www.acpgbi.org.uk/news/ considerations-for-multidisciplinary-management-of-patients-withcolorectal-cancer-during-the-covid-19-pandemic/acpgbi-statement-oncrc-treatment-during-covid-19-final/ SAGES and EAES Recommendations Regarding Surgical Response to COVID-19 Crisis - SAGES [Internet]. [cited 2020 Mar 30]. Available from: https://www.sages.org/recommendations-surgical-response-covid-19/
  3. Lee YH, Kung PT, Wang YH, Kuo WY, Kao SL, Tsai WC. Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study. PLoS One 2019;14:e0210465. Strous MTA, Janssen-Heijnen MLG, Vogelaar FJ. Impact of therapeutic delay in colorectal cancer on overall survival and cancer recurrence – is there a safe timeframe for prehabilitation? Eur J Surg Oncol 2019;45:2295- 2301. Wanis KN, Patel SVB, Brackstone M. Do moderate surgical treatment delays influence survival in colon cancer? Dis Colon Rectum 2017;60:1241-1249.
  4. Flemming JA, Nanji S, Wei X, Webber C, Groome P, Booth CM. Association between the time to surgery and survival among patients with colon cancer: A population-based study. Eur J Surg Oncol 2017;43:1447-1455.
  5. Kucejko RJ, Holleran TJ, Stein DE, Poggio JL. How Soon Should Patients With Colon Cancer Undergo Definitive Resection? Dis Colon Rectum 2020;63:172-182.
  6. Iversen LH, Antonsen S, Laurberg S, Lautrup MD. Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg 2009;96:10-10.
  7. Yun YH, Kim YA, Min YH, Park